AIO LQ-0110: a randomized phase II trial comparing oral doxycycline versus local administration of erythromycin as preemptive treatment strategies of panitumumab-mediated skin toxicity in patients with metastatic colorectal cancer

Melanie Kripp, Nicole Prasnikar, Ursula Vehling-Kaiser, Julia Quidde, Salah-Eddin Al-Batran, Alexander Stein, Kai Neben, Carla Verena Hannig, Hans Werner Tessen, Tanja Trarbach, Axel Hinke, Ralf-Dieter Hofheinz

Open source

DOI: 10.18632/oncotarget.21249
Published: 2017-09-23
Container: Oncotarget
Publisher: Impact Journals, LLC
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.18632/oncotarget.21249,
  title = {AIO LQ-0110: a randomized phase II trial comparing oral doxycycline versus local administration of erythromycin as preemptive treatment strategies of panitumumab-mediated skin toxicity in patients with metastatic colorectal cancer},
  author = {Melanie Kripp and Nicole Prasnikar and Ursula Vehling-Kaiser and Julia Quidde and Salah-Eddin Al-Batran and Alexander Stein and Kai Neben and Carla Verena Hannig and Hans Werner Tessen and Tanja Trarbach and Axel Hinke and Ralf-Dieter Hofheinz},
  year = {2017},
  journal = {Oncotarget},
  doi = {10.18632/oncotarget.21249},
  url = {https://doi.org/10.18632/oncotarget.21249}
}

RIS

TY  - JOUR
TI  - AIO LQ-0110: a randomized phase II trial comparing oral doxycycline versus local administration of erythromycin as preemptive treatment strategies of panitumumab-mediated skin toxicity in patients with metastatic colorectal cancer
AU  - Melanie Kripp
AU  - Nicole Prasnikar
AU  - Ursula Vehling-Kaiser
AU  - Julia Quidde
AU  - Salah-Eddin Al-Batran
AU  - Alexander Stein
AU  - Kai Neben
AU  - Carla Verena Hannig
AU  - Hans Werner Tessen
AU  - Tanja Trarbach
AU  - Axel Hinke
AU  - Ralf-Dieter Hofheinz
PY  - 2017
JO  - Oncotarget
DO  - 10.18632/oncotarget.21249
UR  - https://doi.org/10.18632/oncotarget.21249
ER  -

APA

Kripp, M., Prasnikar, N., Vehling-Kaiser, U., Quidde, J., Al-Batran, S., Stein, A., Neben, K., Hannig, C. V., Tessen, H. W., Trarbach, T., Hinke, A., & Hofheinz, R. (2017). AIO LQ-0110: a randomized phase II trial comparing oral doxycycline versus local administration of erythromycin as preemptive treatment strategies of panitumumab-mediated skin toxicity in patients with metastatic colorectal cancer. Oncotarget. https://doi.org/10.18632/oncotarget.21249

Source records

crossref · retrieved 2026-09-27T15:49:51.978Z